PLx Pharma, Inc.
(NASDAQ : PLXP)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
1.81%17.981.8%$135.39m
ICPTIntercept Pharmaceuticals, Inc.
-1.66%87.6618.6%$84.39m
SAGESAGE Therapeutics, Inc.
0.88%162.898.8%$82.65m
JAZZJazz Pharmaceuticals Plc
0.08%127.782.3%$77.44m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-0.05%155.666.3%$56.48m
PRGOPerrigo Co. Plc
-1.18%49.276.8%$51.44m
ZGNXZogenix, Inc.
-0.26%36.409.9%$41.92m
UTHRUnited Therapeutics Corporation
-1.00%99.6414.3%$38.87m
HZNPHorizon Pharma plc
1.14%24.886.7%$35.89m
CTLTCatalent Inc
2.21%43.702.4%$34.36m
PTLAPortola Pharmaceuticals, Inc.
1.79%33.617.6%$30.78m
ICLRICON Plc
-0.46%130.284.1%$27.18m
MYOKMyoKardia, Inc.
0.68%47.202.4%$25.95m
MNKMallinckrodt Plc
-4.44%18.2821.0%$25.79m
MDCOMedicines Company
1.53%27.9521.8%$24.33m

Company Profile

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development of clinically validated and patent-protected PLxGuard delivery system. Its products include Vazalore 325 mg and PL1200 Ibuprofen 200 mg. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Houston, TX.